The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers

Table 2

Specific ACE/ARB’s used by expose subjects.

	Count (%)
Ramipril	38 (27.5%)
Lisinopril	25 (18.1%)
Enalapril	15 (10.9%)
Monopril	8 (5.8%)
Valsartan	8 (5.8%)
Perindopril	7 (5.1%)
Candesartan	6 (4.3%)
Irbesartan	6 (4.3%)
Losartan	5 (3.6%)
Quinapril	5 (3.6%)
Cilazapril	3 (2.2%)
Fosinopril	3 (2.2%)
Telmisartan	3 (2.2%)
Captopril	2 (1.4%)
Prinivil	1 (0.7%)
Trandolapril	1 (0.7%)
Polytherapy	2 (1.4%)